Changchun University of Chinese Medicine, Changchun, Jilin, China.
Third Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, Jilin, China.
Integr Cancer Ther. 2022 Jan-Dec;21:15347354221101203. doi: 10.1177/15347354221101203.
Ginsenosides, as the most important constituents of ginseng, have been extensively investigated in cancer chemoprevention and therapeutics. Among the ginsenosides, Compound K (CK), a rare protopanaxadiol type of ginsenoside, has been most broadly used for cancer treatment due to its high anticancer bioactivity. However, the functional mechanism of CK in cancer is not well known. This review describes the structure, transformation and pharmacological activity of CK and discusses the functional mechanisms of CK and its metabolites, which regulate signaling pathways related to tumor growth and metastasis. CK inhibits tumor growth by inducing tumor apoptosis and tumor cell differentiation, regulates the tumor microenvironment by suppressing tumor angiogenesis-related proteins, and downregulates the roles of immunosuppressive cells, such as myeloid-derived suppressor cells (MDSCs). There is currently much research on the potential development of CK as a new strategy when administered alone or in combination with other compounds.
人参皂苷作为人参中最重要的成分,在癌症的化学预防和治疗方面已经得到了广泛的研究。在人参皂苷中,由于其高抗癌生物活性,稀有人参二醇型的化合物 K(CK)被最广泛地用于癌症治疗。然而,CK 在癌症中的功能机制尚不清楚。本综述描述了 CK 的结构、转化和药理学活性,并讨论了 CK 及其代谢物的功能机制,这些机制调节与肿瘤生长和转移相关的信号通路。CK 通过诱导肿瘤细胞凋亡和肿瘤细胞分化来抑制肿瘤生长,通过抑制肿瘤血管生成相关蛋白来调节肿瘤微环境,并下调免疫抑制细胞(如髓源性抑制细胞(MDSCs))的作用。目前,人们正在研究 CK 作为一种新策略的潜在发展,无论是单独使用还是与其他化合物联合使用。